Guangzhou Kingmed Diagnostics Group Co., Ltd.
SHH: 603882.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Yaoming Liang
- Employees
- 10,413
- Headquarters
- Guangzhou, China
- IPO year
- 2017
- Market cap
- CN¥13.0B
- Website
- https://www.kingmed.com.cn
Loading 603882…
Loading profile data…Frequently asked questions about 603882
What does Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) do?
Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a third-party medical laboratory company. The company offers medical diagnostic information, clinical trial, lab, food and hygiene testing, health management, medical cold chain logistics, and scientific research services, as well as vitro diagnostics, healthcare big data, artificial inte...
Where does 603882.SS trade?
Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) trades on the Shanghai Stock Exchange.
What sector is 603882.SS in?
Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Guangzhou Kingmed Diagnostics Group Co., Ltd.?
Yaoming Liang is the chief executive officer of Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS).
Where is Guangzhou Kingmed Diagnostics Group Co., Ltd. headquartered?
Guangzhou Kingmed Diagnostics Group Co., Ltd. is headquartered in China.
Does 603882.SS pay a dividend?
Yes — Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) paid a trailing twelve-month dividend of CNY 0.88 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603882.SS go public?
Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) completed its initial public offering in 2017.